Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Return on Equity (2019 - 2025)

Historic Return on Equity for Dna X (SONM) over the last 7 years, with Q3 2025 value amounting to 33.44%.

  • Dna X's Return on Equity rose 342300.0% to 33.44% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.44%, marking a year-over-year increase of 342300.0%. This contributed to the annual value of 4.11% for FY2024, which is 41300.0% down from last year.
  • Latest data reveals that Dna X reported Return on Equity of 33.44% as of Q3 2025, which was up 342300.0% from 26.35% recorded in Q2 2025.
  • Over the past 5 years, Dna X's Return on Equity peaked at 33.44% during Q3 2025, and registered a low of 7.11% during Q4 2024.
  • Over the past 5 years, Dna X's median Return on Equity value was 0.7% (recorded in 2022), while the average stood at 2.26%.
  • In the last 5 years, Dna X's Return on Equity crashed by -71200bps in 2024 and then surged by 342300bps in 2025.
  • Quarter analysis of 5 years shows Dna X's Return on Equity stood at 2.47% in 2021, then skyrocketed by 72bps to 0.7% in 2022, then skyrocketed by 102bps to 0.01% in 2023, then crashed by -48349bps to 7.11% in 2024, then soared by 571bps to 33.44% in 2025.
  • Its last three reported values are 33.44% in Q3 2025, 26.35% for Q2 2025, and 9.13% during Q1 2025.